Search filters

List of works by David Lorente

A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 24 April 2015

A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer

scientific article published on 16 October 2014

Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents

scientific article published on 17 December 2013

Advantages of one step nucleic acid amplification (OSNA) whole node assay in sentinel lymph node (SLN) analysis in breast cancer

scientific article published on 17 October 2013

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.

scientific article published on 11 August 2017

Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.

scientific article

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents.

scientific article

Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.

scientific article published on 8 August 2013

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

scientific article published on 25 September 2013

Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.

scientific article published on 23 December 2014

CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer

scientific article published in November 2015

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses

scientific article published on 05 May 2016

Circulating tumor cells: a multifunctional biomarker

scientific article published on May 2014

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer

scientific article published on 8 June 2016

Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.

scientific article published on 22 November 2016

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

scientific article published on 26 April 2017

Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis

scientific article published on 06 August 2014

External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone

article

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

scientific article published on 29 October 2013

Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey

scientific article published on 10 October 2016

Management of patients with castration-resistant disease.

scientific article published on 20 September 2013

Molecular alterations and emerging targets in castration resistant prostate cancer

scientific article published on 10 January 2014

Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer

scientific article published on January 2014

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience

scientific article published on 01 July 2015

Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids.

scientific article published on 10 May 2017

PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.

scientific article published on 4 November 2014

Progressive computed tomography (CT) appearances preceding malignant spinal cord compression (MSCC) in men with castration-resistant prostate cancer

scholarly article by C Pezaro et al published April 2015 in Clinical Radiology

Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.

scientific article published on 7 March 2016

Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

scientific article published on 13 January 2014

Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.

scientific article published on 3 December 2013

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

scientific article published on 28 December 2017

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

scientific article

Switching and withdrawing hormonal agents for castration-resistant prostate cancer.

scientific article published on January 2015

The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

scientific article

Tumor clone dynamics in lethal prostate cancer

scientific article published on September 2014

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone

scientific article published on 14 October 2014

Visceral disease in castration-resistant prostate cancer.

scientific article published on 22 November 2013

Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer

scientific article

What have we learned from exceptional tumour responses?: Review and perspectives.

scientific article published on May 2015